Canopy Growth Corporation’s CGC share price has surged by 22.22%, which has investors questioning if this is right time to sell.

Be cautious ahead of Canopy Growth Corporation's FQ3 results, as weak financials and low margins may hinder stock performance ...

We recently published a list of 7 Best CBD Stocks To Invest In Right Now. In this article, we are going to take a look at where Canopy Growth Corporation (NASDAQ:CGC) stands against other best CBD ...

Shares in Canopy Growth fell sharply Friday morning after the company's loss missed expectations in the fiscal third quarter. Shares fell over 18% to 3.27 Canadian dollars ($2.29).

Alliance Global Partners analyst Aaron Grey lowered the firm’s price target on Canopy Growth (CGC) to C$4 from C$7 and keeps a Neutral rating ...

Canopy Growth Corporation ( NASDAQ: CGC) Q3 2025 Earnings Conference Call February 7, 2025 10:00 AM ET Aaron Grey - Alliance Global Partners Bill Kirk - ROTH Capital Partners Matt Bottomley - ...

Canopy Growth Corp. reported a loss of $121.9 million in its latest quarter compared with a loss of $216.8 million in the same quarter a year earlier.

The Smiths Falls, Ontario-based cannabis company posted a narrowed net loss of 121.9 million Canadian dollars ($85.2 million), or C$1.11 a share, for the three months ended Dec. 31, compared with a ...

Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.

Reports Q3 revenue C$74.8M vs. C$78.5M last year. “Canopy Growth’s (CGC) third quarter highlights that our business has the right ingredients ...

Strong holiday sales drove Storz & Bickel net revenue growth of 19% year-over-year Record quarter for Canada medical cannabis with net revenue increasing 16%; international ...